
The next generation of GLP-1 drugs: and how they’ll reshape food and beverage again
The GLP-1 phenomenon is only just getting started: what are the next drugs set to hit the market - and are F&B manufacturers ready for the shift?
All stories

The GLP-1 phenomenon is only just getting started: what are the next drugs set to hit the market - and are F&B manufacturers ready for the shift?

The key will be how the spirits giants tackle the US market

Oil is the headline issue: but what else is affected?

The announcement comes as Keurig Dr Pepper completes the acquisition of JDE Peet’s

An emerging functional frontier looks at a key consumer need

The category has taken US shelves by storm over the last couple of years: but what will it look like in 2026 and beyond?

The beverages we choose - and how we find them - is changing

In an era where beer volumes are struggling, alcohol-free beer offers a ray of hope

Trust is key to building brand loyalty and reaching new audiences

Botanicals are the star of the show